Protagenic Therapeutics, Inc. PTIX 深 滬
已收盤 12-19 16:00:00 美东时间
1.19
-0.100
-7.75%
華盛通- 最 高1.31
- 今 開1.30
- 成交量 4.96万股
- 最 低 1.19
- 昨 收 1.29
- 總市值 103.34万
- 52周最高 14.28
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.19
- 委 比 99.35%
- 總股本 86.84万
- 歷史最高 273.84
- 量 比 0.76
- 振 幅 9.30%
- 歷史最低 1.19
- 每 手 1
- 風險率 1.52%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Protagenic Therapeutics Reports Topline Phase 1 Safety Data For PT00114, Was Well Tolerated Across All Dose Ranges Studied; Paves Way For Phase 2 In Stress-Related Neuropsychiatric Conditions
Findings support advancement into Phase 2 to explore a first-in-class pathway aimed at stress-related neuropsychiatric conditionsNEW YORK CITY, NEW YORK / ACCESS Newswire / December 9, 2025 / Protagenic Therapeutics Inc.
12-09 21:48
Protagenic Therapeutics receives Nasdaq non-compliance letter
Protagenic Therapeutics (PTIX) has received a notification letter from Nasdaq indicating its non-compliance with the exchange’s listing rules, namely the minimum stockholders' equity requirement and t...
11-27 19:39
Protagenic Therapeutics Faces Nasdaq Delisting Notice
Protagenic Therapeutics ( ($PTIX) ) just unveiled an announcement. On November ...
11-27 05:49
Protagenic Therapeutics Completes Enrollment, Dosing In Its Multiple Ascending Dose Phase 1 Trial Evaluating PT00114
Protagenic Therapeutics Inc. (NASDAQ:PTIX), a biopharmaceutical company developing novel therapeutics for stress-related neuropsychiatric and neurodegenerative disorders, today announced the successful completion of
11-13 21:26
Jennifer Chao Resigns from Protagenic Therapeutics Board
An announcement from Protagenic Therapeutics ( ($PTIX) ) is now available. On N...
11-06 06:09
Protagenic Therapeutics shares are trading lower after the company filed a complaint to rescind its share exchange agreement by which it acquired Phytanix Bio.
Protagenic Therapeutics shares are trading lower after the company filed a comp...
11-03 22:24
Protagenic Therapeutics Seeks Rescission of Share Agreement
Protagenic Therapeutics ( ($PTIX) ) has shared an update. On October 28, 2025, ...
11-01 05:27
Protagenic Therapeutics May Offer And Sell Shares Of Common Stock Of Up To $1.75M
-SEC Filing
10-25 05:44
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers ModivCare (NASDAQ:MODV) stock increased by 69.6% to $0.95 during Frida...
08-22 20:08
Protagenic Therapeutics (PTIX) Shares Surge On Clinical Trial Progress
Shares of Protagenic Therapeutics are trading sharply higher Thursday afternoon. The stock soared over 100% midday after the company announced a key clinical milestone.
08-22 03:32
